Becton, Dickinson and Co.

U.S. FDA alternate site clearance helps blood glucose meter users

Published in FDA Law Weekly, December 16th, 2004

BD (Becton, Dickinson and Co.)(BDX) announced that it recently received clearance from the U.S. Food and Drug Administration (FDA) that will allow people using the BD Logic and Paradigm Link blood glucose meters to use alternate site testing (off-finger) when checking their blood glucose levels.

"This is great news for people with diabetes," said Bill Marshall, president, diabetes care, BD medical. "Coupled with the BD Ultra-Fine 33 gauge Lancets - the thinnest lancet on the market - this clearance by the FDA equating palm testing with fingertip testing for users of the BD Logic and Paradigm Link provides people a more convenient and comfortable 'best in class' approach...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of FDA Law Weekly

Source: FDA Law Weekly (2004-12-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry